With multiple databases, our pan-cancer analysis explored the association of MARCH8 genetic alteration, expression, clinical relevance, prognosis, tumor microenvironment (TME), and immune checkpoint (ICP) genes across cancer types. This evidence concerns the gene MARCHF8 and cancer.